AKT1 and cancer: Although the precise molecular mechanisms for the development of chemoresistance are poorly understood, accumulating evidence has indicated that the activation of the PI3K/Akt pathway is involved in the acquisition of resistance to chemotherapeutic agents in human cancers [6, 14].